Effect of Polymer Hydrophilicity and Molar Mass on the Properties of the Protein in Protein-Polymer Conjugates: The Case of PPEylated Myoglobin.


Journal

Biomacromolecules
ISSN: 1526-4602
Titre abrégé: Biomacromolecules
Pays: United States
ID NLM: 100892849

Informations de publication

Date de publication:
10 05 2021
Historique:
pubmed: 9 4 2021
medline: 22 6 2021
entrez: 8 4 2021
Statut: ppublish

Résumé

Polyphosphoesters (PPEs), a versatile class of biodegradable and biocompatible polymers, have been proposed as alternatives to poly(ethylene glycol) (PEG), which is suspected to be responsible for anaphylactic reactions in some patients after the administration of PEGylated compounds, e.g., in the current Covid-19 vaccines. We present the synthesis and characterization of a novel set of protein-polymer conjugates using the model protein myoglobin and a set of PPEs with different hydrophilicity and molar mass. We report an extensive evaluation of the (bio)physical properties of the protein within the conjugates, studying its conformation, residual activity, and thermal stability by complementary techniques (UV-vis spectroscopy, nano-differential scanning calorimetry, and fluorometry). The data underline the systematic influence of polymer hydrophilicity on protein properties. The more hydrophobic polymers destabilize the protein, the more hydrophilic PPEs protect against thermally induced aggregation and proteolytic degradation. This basic study aims at guiding the design of future PPEylated drugs and protein conjugates.

Identifiants

pubmed: 33830737
doi: 10.1021/acs.biomac.1c00058
pmc: PMC8154264
doi:

Substances chimiques

COVID-19 Vaccines 0
Myoglobin 0
Polymers 0
Polyethylene Glycols 3WJQ0SDW1A

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1932-1943

Références

Bioconjug Chem. 2011 May 18;22(5):976-86
pubmed: 21452890
J Pharmacol Toxicol Methods. 2020 Mar - Apr;102:106678
pubmed: 31981619
J Biotechnol. 2014 Jul 10;181:55-63
pubmed: 24709400
Biomacromolecules. 2019 Jan 14;20(1):222-230
pubmed: 30512933
Bioconjug Chem. 1993 Nov-Dec;4(6):568-9
pubmed: 8305527
Biophys J. 1995 May;68(5):2091-7
pubmed: 7612852
Biomacromolecules. 2020 Feb 10;21(2):349-355
pubmed: 31687811
Eur J Biochem. 2001 Oct;268(20):5439-48
pubmed: 11606207
Biophys Chem. 2014 Jan;185:25-31
pubmed: 24309207
Biomacromolecules. 2016 Jan 11;17(1):141-7
pubmed: 26568153
Angew Chem Int Ed Engl. 2010 Aug 23;49(36):6288-308
pubmed: 20648499
Polym Chem. 2019 Jan 28;10(4):434-454
pubmed: 31249635
Chem Commun (Camb). 2020 Feb 25;56(16):2415-2418
pubmed: 31994584
Biomacromolecules. 2018 Apr 9;19(4):1212-1222
pubmed: 29526096
Polymers (Basel). 2018 May 14;10(5):
pubmed: 30966561
Biophys J. 1992 Apr;61(4):921-35
pubmed: 19431826
Angew Chem Int Ed Engl. 2018 May 4;57(19):5548-5553
pubmed: 29479798
Crit Rev Biotechnol. 2001;21(4):219-32
pubmed: 11797908
Adv Drug Deliv Rev. 2010 Feb 17;62(2):272-82
pubmed: 20005271
Biomacromolecules. 2016 Oct 10;17(10):3338-3346
pubmed: 27618845
Nat Nanotechnol. 2016 Apr;11(4):372-7
pubmed: 26878141
Blood Transfus. 2010 Jun;8 Suppl 3:s59-68
pubmed: 20606751
J Agric Food Chem. 2003 Sep 10;51(19):5815-23
pubmed: 12952438
Toxicol Lett. 1998 Nov 23;100-101:387-91
pubmed: 10049169
Macromol Biosci. 2017 Oct;17(10):
pubmed: 27943530
Biochemistry. 2010 Jul 27;49(29):6052-63
pubmed: 20540498
J Pharm Sci. 2016 Feb;105(2):460-475
pubmed: 26869412
J Biol Chem. 1985 Sep 5;260(19):10458-60
pubmed: 4030754
Biomacromolecules. 2018 Apr 9;19(4):1130-1141
pubmed: 29514006
Curr Opin Chem Biol. 2015 Oct;28:181-93
pubmed: 26356631
Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15231-6
pubmed: 19706892
Macromol Biosci. 2020 Jun;20(6):e1900410
pubmed: 32285628
Br J Anaesth. 2021 Mar;126(3):e106-e108
pubmed: 33386124
J Mol Biol. 1974 Jul 5;86(3):665-84
pubmed: 4368360
Nano Lett. 2020 Jan 8;20(1):526-533
pubmed: 31789526
Science. 2015 Oct 23;350(6259):445-50
pubmed: 26359336
Biophys Chem. 2007 Mar;126(1-3):16-24
pubmed: 16781052
Bioconjug Chem. 2008 Jan;19(1):299-305
pubmed: 18020402

Auteurs

Chiara Pelosi (C)

Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Via Moruzzi, Pisa 56124, Italy.

Celia Duce (C)

Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Via Moruzzi, Pisa 56124, Italy.

Frederik R Wurm (FR)

Sustainable Polymer Chemistry, Department of Molecules and Materials, MESA+ Institute for Nanotechnology, Faculty of Science and Technology, Universiteit Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands.

Maria R Tinè (MR)

Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Via Moruzzi, Pisa 56124, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH